Winton Group LTD Myovant Sciences Ltd. Transaction History

Winton Group LTD

  • $1.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$14.31 - $23.87 $182,910 - $305,106
-12,782 Closed
0 $0
Q3 2021

Oct 28, 2021
BUY
$18.94 - $26.99 $242,091 - $344,986
12,782 New
12,782 $287,000
Q4 2019

Feb 13, 2020
SELL
$4.2 - $19.21 $139,847 - $639,635
-33,297 Closed
0 $0
Q3 2019

Nov 08, 2019
BUY
$5.19 - $9.46 $172,811 - $314,989
33,297 New
33,297 $173,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email